Research output per year
Research output per year
Asier Unciti-Broceta, Loredana Moggio, Kevin Dhaliwal, Laura Pidgeon, Keith Finlayson, Chris Haslett, Mark Bradley
Research output: Contribution to journal › Article › peer-review
The therapeutic use of nucleic acids has long been heralded as a panacea of medicinal opportunity, a vision enhanced by the introduction of RNA interference technology. The Achilles heel of such an approach is the in vivo delivery of the desired nucleic acid into cells, a practice that lacks selectivity, safety and/or efficiency. Herein we report the safe and efficacious in vitro and in vivo delivery of nucleic acids using tripodal biodegradable cationic lipids. Toxicity reduction and transfection potency of these novel amphiphiles were addressed by designing the compounds to undergo complete intracellular degradation thereby enhancing cargo release while minimising toxicity and potential tissue accumulation. Compounds demonstrated high-efficiency in transfecting DNA into cells both in vitro and in vivo with no signs of toxicity, thus potentially offering a safer alternative to viral transfection for gene therapy application.
Original language | English |
---|---|
Pages (from-to) | 2154-2158 |
Number of pages | 5 |
Journal | Journal of Materials Chemistry |
Volume | 21 |
Issue number | 7 |
DOIs | |
Publication status | Published - 2011 |
Research output: Contribution to journal › Article › peer-review
Research output: Patent
Asier Unciti-Broceta (Interviewee)
Activity: Other activity types › Types of Public engagement and outreach - Media article or participation
Asier Unciti-Broceta (Interviewee)
Activity: Other activity types › Types of Public engagement and outreach - Media article or participation